<SEC-DOCUMENT>9999999995-21-001826-index.html : 20210507
<SEC-HEADER>9999999995-21-001826.hdr.sgml : 20210507
<ACCEPTANCE-DATETIME>20210507001536
ACCESSION NUMBER:		9999999995-21-001826
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210506
DATE AS OF CHANGE:		20210507
EFFECTIVENESS DATE:		20210506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Talaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001827506
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-255316
		FILM NUMBER:		21900055

	BUSINESS ADDRESS:	
		STREET 1:		201 E. JEFFERSON ST., SUITE 110B
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		502-569-1059

	MAIL ADDRESS:	
		STREET 1:		201 E. JEFFERSON ST., SUITE 110B
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>